- Oral opioid vs intravenous patient-controlled analgesia (PCA) with hydromorphone bolus-only or continuous infusion to maintain analgesia for severe cancer pain: A randomized phase III trialLin, R.; He, L.; Lu, M.; Wang, Y.; Liu, J.; Li, Q.; Lu, X.; Zhuang, L.; Zhang, Z.; Gong, L.; Luo, Y.; Cao, L.; Zhong, J.; Zou, H.; Ren, T.; Shang, C.; Lin, S.; Zhao, S.; Su, L.; Huang, C.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
- Multicenter, randomized, double-blind, controlled trial of transcutaneous electrical nerve stimulation for pancreatic cancer related painLihua, He; Keping, Tan; Xianming, Lin; Hui, Yi; Xueliang, Wang; Jiangsong, Zhang; Jietao, Lin; Lizhu, LinMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(5): e23748.
- Pharmacological Evaluation of Morphine and Non-opioid Analgesic Adjuvants in a Mouse Model of Skin Cancer PainTsugunobu, Andoh; Kenji, Sugiyama; Masahide, Fujita; Yuko, Iida; Hiroshi, Nojima; Ikuo, Saiki; Yasushi, KuraishiBiological and Pharmaceutical Bulletin, 2008, 31(3): 520-522.被引 16
会议论文
Oxycodone/naloxone in moderate-to-severe cancer pain: A phase III study in China
4阅读
